France increases spending on MRI (magnetic resonance imaging) and other technology
This article was originally published in Clinica
Despite uncertainties over forthcoming changes in reimbursement for medical technology in France (see pp 8-9), there is some good news for industry - magnetic resonance imaging (MRI) is benefiting from increased government investment.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.